Rosiglitazone attenuates the severity of hyperlipidemic severe acute pancreatitis in rats

Experimental and Therapeutic Medicine

Volumn 6, Issue 4, 2013, Pages 989-994

  Niyaz, Batur ^a   Zhao, Kai Liang ^a   Liu, Li Min ^b   Chen, Chen ^a   Deng, Wen Hong ^a   Zuo, Teng ^a   Shi, Qiao ^a   Wang, Wei Xing ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Ezhou Central Hospital   (China)

Author keywords

Acute pancreatitis; Cytokine; Hyperlipidemia; Ligand; Peroxisome proliferator activated receptor

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; AMYLASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSIGLITAZONE; TAUROCHOLIC ACID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DISEASE SEVERITY; HISTOPATHOLOGY; HYPERLIPIDEMIA; LIPID DIET; MALE; NONHUMAN; PANCREAS INJURY; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; WESTERN BLOTTING;

EID: 84883239206     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1255     Document Type: Article

References (44)

1. Gan SI, Edwards AL, Symonds CJ and Beck PL: Hypertriglyceridemia-induced pancreatitis: A case-based review. World J Gastroentrol 12: 7197-7202, 2006.
2. Dubuquoy L, Rousseaux C, Thuru X, et al: PPARgamma as a new therapeutic in inflammatory bowel diseases. Gut 55: 1341-1349, 2006.
3. Kapadia R, Yi JH and Vemuganti R: Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci 13: 1813-1826, 2008.
4. Chawla A, Schwarz EJ, Dimaculangan DD and Lazar MA: Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135: 798-800, 1994.
5. Nolan JJ, Ludvik B, Beerdsen P, Joyce M and Olefsky J: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. New Engl J Med 331: 1188-1193, 1994.
6. Lehrke M and Lazar MA: The many faces of PPARgamma. Cell 123: 993-999, 2005.
7. Zhang Q, Hu PPARγ agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats W, Meng B and Tang T:. Neurol Res 32: 852-859, 2010.
8. Esposito E and Cuzzocrea S: Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury. Expert Opin Ther Targets 15: 943-959, 2011.
9. Di Paola R, Mazzon E, Maiere D, et al: Rosiglitazone reduces the evolution of experimental periodontitis in the rat. J Dent Res 85: 156-161, 2006.
10. Cuzzocrea S, Pisano B, Dugo L, et al: Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. Br J Pharmacol 140: 366-376, 2003.
11. Paszkowski AS, Rau B, Mayer JM, Möller P and Beger HG: Therapeutic application of caspase 1/interleukin-1beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis. Ann Surg 235: 68-76, 2002.
12. Bjelik A, Bereczki E, Gonda S, et al: Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis. Neurochem Int 49: 393-400, 2006.
13. Grewal HP, Moheyel Din A, Gaber L, Kotb M and Gaber AO: Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. Am J Surg 167: 214-219, 1994.
14. Werner J, Z'Graggen K, Fernández-del Castillo C, et al: Specific therapy for local and systemic complications of acute pancreatitis with monoclonal antibodies against ICAM-1. Ann Surg 229: 834-842, 1999.
15. Saharia P, Margolis S, Zuidema GD and Cameron JL: Acute pancreatitis with hyperlipidemia: Studies with an isolated perfused canine pancreas. Surgery 82: 60-67, 1977.
16. Hofbauer B, Friess H, Weber A, et al: Hyperlipaemia intensifies the course of acute oedematous and acute necrotising pancreatitis in the rat. Gut 38: 753-758, 1996.
17. Kimura W and Mössner J: Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int J Pancreatol 20: 177-184, 1996.
18. Blanquart C, Barbier O, Fruchart JC, Staels B and Glineur C: Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol 85: 267-273, 2003.
19. Escher P and Wahli W: Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 448: 121-138, 2000.
20. Mrówka P and Głodkowska-Mrówka E: Structure, function and role of peroxisome proliferator-activated receptor-gamma - PPARγ. Postepy Bilol Komorki 38: 629-651, 2011.
21. Sun X, Tang Y, Tan X, et al: Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice. Am J Physiol Gastrointest Liver Physiol 302: G548-G557, 2012.
22. Kouidhi S, Seugnet I, Decherf S, Guissouma H, Elgaaied AB, Demeneix B and Clerget-Friodevaux MS: Peroxisome proliferator-activated receptor-gamma (PPARgamma) modulates hypothalamic Trh regulation in vivo. Mol Cell Endocrinol 317: 44-52, 2010.
23. Chen C, Xu S, Wang WX, Ding YM, Yu KH, Wang B and Chen XY: Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury. Arch Med Res 40: 79-88, 2009.
24. Cai Q and Xu MY: Protective effect of rosiglitazone against hyperoxia-induced lung injury in neonatal rats. Zhongguo Dang Dai Er Ke Za Zhi 14: 301-305, 2012 (In Chinese).
25. Bassaganya-Riera J, Viladomiu M, Pedragosa M, et al: Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis. PLoS One 7: e31238, 2012.
26. Buss Zda S, Medeiros YS and Fröde TS: PPAR-gamma agonist rosiglitazone attenuates the inflammation caused by carrageenan in the mouse model of pleurisy. Inflammation 35: 280-288, 2012.
27. Lin TN, Cheung WM, Wu JS, et al: 15d-Prostaglandin J2 protects brain from ischemia-reperfusion injury. Arterioscl Throm Vasc Biol 26: 481-487, 2006.
28. Inoue K, Takano H, Yanagisawa R, et al: Effect of 15-deoxy-delta 12,14-prostaglandin J2 on acute lung injury induced by lipopolysaccharide in mice. Eur J Pharmacol 481: 261-269, 2003.
29. Ricote M, Li AC, Willson TM, Kelly CJ and Glass CK: The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82, 1998.
30. Ricote M and Glass CK: PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta 1771: 926-935, 2007.
31. Lim HA, Lee EK, Kim JM, et al: PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney. Biogerontology 13: 133-145, 2012.
32. Kelly D, Campbell JI, King TP, et al: Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and ReIA. Nat Immunol 5: 104-112, 2004.
33. Babu SK, Puddicombe SM, Arshad HH, et al: Tumor necrosis factor alpha (TNF-α) autoregulates its expression and induces adhesion molecule expression in asthma. Clin Immunol 140: 18-25, 2011.
34. Hsu WY, Chao YW, Tsai YL, et al: Resistin induces monocyte-endothelial cell adhesion by increasing ICAM-1 and VCAM-1 expression in endothelial cells via p38MAPK-dependent pathway. J Cell Physiol 226: 2181-2188, 2011.
35. Yang CM, Luo SF, Hsieh HL, et al: Interleukin-1beta induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: Involvement of ERK, JNK, AP-1, and NF-kappaB. J Cell Physiol 224: 516-526, 2010.
36. Zhang XD, Hou JF, Qin XJ, et al: Pentoxifylline inhibits intercellular adhesion molecule-1 (ICAM-1) and lung injury in experimental phosgene-exposure rats. Inhal Toxicol 22: 889-895, 2010.
37. Bernot D, Peiretti F, Canault M, Juhan-Vague I and Nalbone G: Upregulation of TNF-alpha-induced ICAM-1 surface expression by adenylate cyclase-dependent pathway in human endothelial cells. J Cell Physiol 202: 434-441, 2005.
38. Frossard JL, Saluja A, Bhagat L, et al: The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 116: 694-701, 1999.
39. Lundberg AH, Granger DN, Russell J, et al: Temporal correlation of tumor necrosis factor-alpha release, upregulation of pulmonary ICAM-1 and VCAM-1, neutrophil sequestration, and lung injury in diet-induced pancreatitis. J Gastrointest Surg 4: 248-257, 2000.
40. Cuzzocrea S, Pisano B, Dugo L, et al: Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein. Intensive Care Med 30: 951-956, 2004.
41. Laveda R, Martinez J, Munoz C, et al: Different profile of cytokine synthesis according to the severity of acute pancreatitis. World J Gastroenterol 11: 5309-5313, 2005.
42. Zhang XP, Ye Q, Jiang XG, et al: Preparation method of an ideal model of multiple organ injury of rat with severe acute pancreatitis. World J Gastroentrol 13: 4566-4573, 2007.
43. Gulcubuk A, Altunatmaz K, Sonmez K, et al: Effects of curcumin on tumour necrosis factor-alpha and interleukin-6 in the late phase of experimental acute pancreatitis. J Vet Med A Physiol Pathol Clin Med 53: 49-54, 2006.
44. Gulben K, Ozdemir H, Berberoǧlu U, et al: Melatonin modulates the severity of taurocholate-induced acute pancreatitis in the rat. Dig Dis Sci 55: 941-946, 2010.